271 related articles for article (PubMed ID: 11696633)
1. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET.
Lehtiö K; Oikonen V; Grönroos T; Eskola O; Kalliokoski K; Bergman J; Solin O; Grénman R; Nuutila P; Minn H
J Nucl Med; 2001 Nov; 42(11):1643-52. PubMed ID: 11696633
[TBL] [Abstract][Full Text] [Related]
2. Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio.
Lehtiö K; Oikonen V; Nyman S; Grönroos T; Roivainen A; Eskola O; Minn H
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):101-8. PubMed ID: 12483416
[TBL] [Abstract][Full Text] [Related]
3. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer.
Lehtiö K; Eskola O; Viljanen T; Oikonen V; Grönroos T; Sillanmäki L; Grénman R; Minn H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):971-82. PubMed ID: 15234030
[TBL] [Abstract][Full Text] [Related]
4. Measuring tumor hypoxia with ¹⁸F-FETNIM PET in esophageal squamous cell carcinoma: a pilot clinical study.
Yue J; Yang Y; Cabrera AR; Sun X; Zhao S; Xie P; Zheng J; Ma L; Fu Z; Yu J
Dis Esophagus; 2012 Jan; 25(1):54-61. PubMed ID: 21595781
[TBL] [Abstract][Full Text] [Related]
5. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J
J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
Grönroos TJ; Lehtiö K; Söderström KO; Kronqvist P; Laine J; Eskola O; Viljanen T; Grénman R; Solin O; Minn H
BMC Cancer; 2014 Nov; 14():876. PubMed ID: 25421331
[TBL] [Abstract][Full Text] [Related]
7. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of [18F]FETNIM: a potential marker for PET.
Grönroos T; Eskola O; Lehtiö K; Minn H; Marjamäki P; Bergman J; Haaparanta M; Forsback S; Solin O
J Nucl Med; 2001 Sep; 42(9):1397-404. PubMed ID: 11535732
[TBL] [Abstract][Full Text] [Related]
9. 18F-EF5: a new PET tracer for imaging hypoxia in head and neck cancer.
Komar G; Seppänen M; Eskola O; Lindholm P; Grönroos TJ; Forsback S; Sipilä H; Evans SM; Solin O; Minn H
J Nucl Med; 2008 Dec; 49(12):1944-51. PubMed ID: 18997048
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.
Wang W; Lee NY; Georgi JC; Narayanan M; Guillem J; Schöder H; Humm JL
J Nucl Med; 2010 Jan; 51(1):37-45. PubMed ID: 20008982
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia imaging of uterine cervix carcinoma with (18)F-FETNIM PET/CT.
Vercellino L; Groheux D; Thoury A; Delord M; Schlageter MH; Delpech Y; Barré E; Baruch-Hennequin V; Tylski P; Homyrda L; Walker F; Barranger E; Hindié E
Clin Nucl Med; 2012 Nov; 37(11):1065-8. PubMed ID: 22996235
[TBL] [Abstract][Full Text] [Related]
12. A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
Wei Y; Zhao W; Huang Y; Yu Q; Zhu S; Wang S; Zhao S; Hu X; Yu J; Yuan S
PLoS One; 2016; 11(6):e0157606. PubMed ID: 27322586
[TBL] [Abstract][Full Text] [Related]
13. PET imaging of tumor hypoxia using 18F-labeled pimonidazole.
Busk M; Jakobsen S; Horsman MR; Mortensen LS; Iversen AB; Overgaard J; Nordsmark M; Ji X; Lee DY; Raleigh JR
Acta Oncol; 2013 Oct; 52(7):1300-7. PubMed ID: 23962243
[TBL] [Abstract][Full Text] [Related]
14. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia with 18F-fluoroerythronitroimidazole integrated positron emission tomography and computed tomography (18F-FETNIM PET/CT) in locoregionally advanced head and neck cancer: Hypoxia changes during chemoradiotherapy and impact on clinical outcome.
Hu M; Xie P; Lee NY; Li M; Ho F; Lian M; Zhao S; Yang G; Fu Z; Zheng J; Ma L; Yu J
Medicine (Baltimore); 2019 Oct; 98(40):e17067. PubMed ID: 31577699
[TBL] [Abstract][Full Text] [Related]
16. Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study.
Souvatzoglou M; Grosu AL; Röper B; Krause BJ; Beck R; Reischl G; Picchio M; Machulla HJ; Wester HJ; Piert M
Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1566-75. PubMed ID: 17447061
[TBL] [Abstract][Full Text] [Related]
17. Quantitative assessment of hypoxia kinetic models by a cross-study of dynamic 18F-FAZA and 15O-H2O in patients with head and neck tumors.
Shi K; Souvatzoglou M; Astner ST; Vaupel P; Nüsslin F; Wilkens JJ; Ziegler SI
J Nucl Med; 2010 Sep; 51(9):1386-94. PubMed ID: 20720045
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric Analysis of the Relationship Between Tumor Hypoxia and Perfusion with ¹⁸F-Fluoroazomycin Arabinoside and ¹⁵O-H₂O PET.
Iqbal R; Kramer GM; Verwer EE; Huisman MC; de Langen AJ; Bahce I; van Velden FH; Windhorst AD; Lammertsma AA; Hoekstra OS; Boellaard R
J Nucl Med; 2016 Apr; 57(4):530-5. PubMed ID: 26659349
[TBL] [Abstract][Full Text] [Related]
19. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
[TBL] [Abstract][Full Text] [Related]
20. Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia.
Yang DJ; Wallace S; Cherif A; Li C; Gretzer MB; Kim EE; Podoloff DA
Radiology; 1995 Mar; 194(3):795-800. PubMed ID: 7862981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
